Cluster analysis identifies characteristic phenotypes of asthma with accelerated lung function decline

Journal of Asthma

Volumn 51, Issue 2, 2014, Pages 113-118

  Sakagami, Takuro ^a   Hasegawa, Takashi ^b   Koya, Toshiyuki ^a   Furukawa, Toshiki ^a   Kawakami, Hidenori ^a   Kimura, Yosuke ^a   Hoshino, Yoshifumi ^a   Sakamoto, Hirotaka ^a   Shima, Kenjiro ^a   Kagamu, Hiroshi ^a   Suzuki, Ei Ichi ^b   Narita, Ichiei ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Asthma in the elderly; Asthma management guidelines; Inhaled corticosteroid therapy; Phenotypes; Rapid lung function decline

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; ATOPY; CHILD; CLINICAL FEATURE; CLUSTER ANALYSIS; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHENOTYPE; PHYLOGENETIC TREE; PRACTICE GUIDELINE; PRESCHOOL CHILD; SCHOOL CHILD; SMOKING; STEP WISE MULTIPLE REGRESSION; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; AGED; ASTHMA; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; IMMUNOGLOBULIN E; INFANT; INTERLEUKIN-13; LEUKOTRIENE ANTAGONISTS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; VITAL CAPACITY; YOUNG ADULT;

EID: 84894428585     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2013.852201     Document Type: Article

References (28)

1. Peat JK, Woolcock AJ, Cullen K. Rate of decline of lung function in subjects with asthma. Eur J Respir Dis 1987;70:171-179
2. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year followup study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200
3. Dijkstra A, Vonk JM, Jongepier H, Koppelman GH, Schouten JP, ten Hacken NH, Timens W, Postma DS. Lung function decline in asthma: Association with inhaled corticosteroids, smoking and sex. Thorax 2006;61:105-110
4. Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J 2007; 30:452-456
5. OByrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009;179:19-24
6. Marcon A, Corsico A, Cazzoletti L, Bugiani M, Accordini S, Almar E, Cerveri I, et al. Body mass index, weight gain, and other determinants of lung function decline in adult asthma. J Allergy Clin Immunol 2009;123:1069-1074, 74 e1-4
7. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368:780-793
8. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, DAgostino Jr R, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315-323
9. Fitzpatrick AM, Teague WG, Meyers DA, Peters SP, Li X, Li H, Wenzel SE, et al. Heterogeneity of severe asthma in childhood: Confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol 2010; 127:382-389, e1-13
10. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multidimensional phenotyping: Towards a new taxonomy for airway disease. Clin Exp Allergy 2005;35:1254-1262
11. Wenzel SE. Asthma: Defining of the persistent adult phenotypes. Lancet 2006;368:804-813
12. Heaney LG, Robinson DS. Severe asthma treatment: Need for characterising patients. Lancet 2005;365:974-976
13. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S, Beasley R. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34:812-818
14. Silverstein MD, Reed CE, OConnell EJ, Melton III LJ, OFallon WM, Yunginger JW. Long-Term survival of a cohort of community residents with asthma. N Engl J Med 1994;331: 1537-1541
15. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 1996;347: 1285-1289
16. Ulrik CS. Outcome of asthma: Longitudinal changes in lung function. Eur Respir J 1999;13:904-918
17. Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994;150:629-634
18. James AL, Palmer LJ, Kicic E, Maxwell PS, Lagan SE, Ryan GF, Musk AW. Decline in lung function in the Busselton Health Study: The effects of asthma and cigarette smoking. Am J Respir Crit Care Med 2005;171:109-114
19. de Marco R, Marcon A, Jarvis D, Accordini S, Bugiani M, Cazzoletti L, Cerveri I, et al. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol 2007;119:611-617
20. Miranda C, Busacker A, Balzar S, Trudeau J, Wenzel SE. Distinguishing severe asthma phenotypes: Role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004;113: 101-108
21. Matsunaga K, Akamatsu K, Miyatake A, Ichinose M. Natural history and risk factors of obstructive changes over a 10-year period in severe asthma. Respir Med 2013;107:355-360
22. Hudon C, Turcotte H, Laviolette M, Carrier G, Boulet LP. Characteristics of bronchial asthma with incomplete reversibility of airflow obstruction. Ann Allergy Asthma Immunol 1997;78: 195-202
23. Ward Jr JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963;48:236-244
24. Mark Hall EF, Holmes G, Pfahringer B, Reutemann P, Witten IH. The WEKA data mining software: An update. SIGKDD Explorations 2009;11:10-18 .
25. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy 2000;30:2-5
26. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143-178
27. Selroos O, Pietinalho A, Lofroos AB, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-1234
28. Koyanagi K, Koya T, Sasagawa M, Hasegawa T, Suzuki E, Arakawa M, Gejyo F. An analysis of factors that exacerbate asthma, based on a Japanese questionnaire. Allergol Int 2009;58:519-527